Venturi Wealth Management LLC Increases Position in ICU Medical, Inc. (NASDAQ:ICUI)

Venturi Wealth Management LLC increased its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 64.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 528 shares of the medical instruments supplier’s stock after purchasing an additional 206 shares during the quarter. Venturi Wealth Management LLC’s holdings in ICU Medical were worth $82,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Allworth Financial LP increased its position in shares of ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 100 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in ICU Medical in the 3rd quarter valued at $72,000. Greenleaf Trust purchased a new stake in ICU Medical in the 3rd quarter worth $207,000. Coldstream Capital Management Inc. acquired a new position in ICU Medical during the third quarter worth $227,000. Finally, OLD National Bancorp IN raised its position in ICU Medical by 22.0% during the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier’s stock worth $227,000 after acquiring an additional 264 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Performance

NASDAQ:ICUI opened at $157.42 on Monday. The company has a market cap of $3.85 billion, a P/E ratio of -34.45 and a beta of 0.63. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26. The company’s 50-day moving average price is $160.74 and its 200-day moving average price is $166.22. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, December 11th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Finally, KeyCorp raised their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $199.67.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $17,039,245.63. This represents a 10.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David C. Greenberg sold 972 shares of the firm’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total value of $153,682.92. Following the completion of the sale, the director now directly owns 5,037 shares of the company’s stock, valued at $796,400.07. This trade represents a 16.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,775 shares of company stock worth $2,548,017. Insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.